Purpose of the company: Distribution of medical devices, as well as performing maintenance work and selling accessories. The OXYVEN treatment device, designed by Dr. H. S. Regelsberger, is marketed. Manufacturing is carried out by an external company.
Adress: Brookstr. 31 a 49811 Lingen Deutschland
Local court: 49074 Osnabrück
Register number: HRA100146
The average total assets of company Oxyven-Geräte Dr. med. H.S. Regelsberger GmbH & Co. over the last 4 years is 482.398,19 €.
The company Oxyven-Geräte Dr. med. H.S. Regelsberger GmbH & Co. as of the reporting date 2022 a bank balance of approx. 24.279,59 €. That is -74,32 % less than the average bank balance in the industry of companies with this total assets.
The equity ratio of Oxyven-Geräte Dr. med. H.S. Regelsberger GmbH & Co. is 23,07 % in the year 2022. In total, that ist 105.057,60 €.
The average absolute change in liquidity of the company Oxyven-Geräte Dr. med. H.S. Regelsberger GmbH & Co. compared to the previous year amounts to -22.114,17 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company Oxyven-Geräte Dr. med. H.S. Regelsberger GmbH & Co. amounts to -66.342,50 € in the year 2022.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.